Summary
IDEXX Laboratories, Inc. reported solid revenue growth for the six months ended June 30, 2015, with total revenue increasing by 6.1% year-over-year to $795.8 million. This growth was primarily driven by the Companion Animal Group (CAG) segment, which saw an 8.9% increase in revenue, particularly in recurring diagnostics revenue. The company successfully transitioned to an all-direct sales strategy in the U.S., which is contributing to distributor margin capture and influencing revenue growth. Despite a challenging foreign currency environment impacting international revenue, IDEXX demonstrated resilience. Financially, the company maintained profitability, with net income attributable to IDEXX stockholders at $103.5 million for the first six months. The balance sheet shows a significant increase in long-term debt, reflecting recent note issuances to fund general corporate purposes. While cash flow from operations decreased compared to the prior year, primarily due to changes in working capital, the company maintained sufficient liquidity through its credit facility and cash reserves.
Financial Highlights
54 data points| Revenue | $413.34M |
| Cost of Revenue | $180.59M |
| Gross Profit | $232.76M |
| R&D Expenses | $24.32M |
| Operating Income | $88.30M |
| Interest Expense | $7.26M |
| Net Income | $56.91M |
| EPS (Basic) | $0.61 |
| EPS (Diluted) | $0.60 |
| Shares Outstanding (Basic) | 93.38M |
| Shares Outstanding (Diluted) | 94.31M |
Key Highlights
- 1Total revenue increased by 6.1% to $795.8 million for the six months ended June 30, 2015, compared to the same period in 2014.
- 2Companion Animal Group (CAG) was the primary growth driver, with revenue up 8.9% to $676.1 million, largely due to recurring diagnostics revenue.
- 3The company successfully completed the transition to an all-direct sales strategy in the U.S., which is contributing to revenue growth through distributor margin capture.
- 4Net income attributable to stockholders was $103.5 million for the first six months of 2015.
- 5Long-term debt increased significantly due to the issuance of new senior notes, totaling approximately $250 million during the period.
- 6Cash flow from operating activities decreased by $49.8 million to $65.5 million for the six months ended June 30, 2015, impacted by changes in working capital.
- 7The company reported $163.2 million in cash and cash equivalents as of June 30, 2015, and had $201.0 million in remaining borrowing availability under its credit facility.